Unlicensed use for orthostatic intolerance disorders e.g. postural orthostatic tachycardia syndrome (PoTS)
Sandostatin, Sandostatin LAR®
Immune system and Malignant Disease
NOT recommended for use by the NHS in Lancashire & South Cumbria
There is insufficient evidence of the effectiveness of octreotide and lanreotide in orthostatic intolerance disorders.
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria